Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Preqin finds Asia Pacific hedge funds enjoy strongest start to 2013

Wednesday, March 27, 2013
Opalesque Industry Update - Preqin’s latest Hedge Fund Spotlight reveals that hedge funds focusing on the Asia - Pacific region posted significant returns in January and February 2013, posting 3.97% and 2.18% in each month respectively.

This is in comparison to North American and European hedge funds, which posted only 0.61% and 1.24% in February respectively. Other Key Facts:

  • Asia - Pacific hedge funds outperformed other regions over the last 12 months, returning 10.71% compared to 9.37% for North America - focused hedge funds and 6.88% for Europe - focused hedge funds.
  • Performance for hedge funds across all strategies and regions declined from 2.47% in January to 0.39% in February.
  • Emerging markets - focused funds posted negative returns in February of - 0.08%.
  • Funds of hedge funds across all strategies and regions posted only 0.05% in February, after a strong January with returns of 2.10%.
  • Other findings in this month’s Preqin Hedge Fund Spotlight demonstrate that 79% of investors believe that hedge fund performance in 2013 will beat that of 2012.

“Preqin’s February benchmarks indicate that it was a relatively flat month for most hedge funds. However, hedge funds targeting Asia - Pacific markets continued with their strong start to the year as Japanese stocks maintained an upward trajectory.” said Joe Childs, Manager - Hedge Fund Performance.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for